Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract
- 1 August 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (8), 1131-1133
- https://doi.org/10.1016/0277-5379(87)90145-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Adriamycin Chemotherapy for Malignant Mixed Mesodermal Tumor of the Ovary A Gynecologic Oncology Group StudyAmerican Journal of Clinical Oncology, 1986
- Patterns of recurrence in malignant mixed müllerian tumor of the uterusCancer, 1986
- Uterine sarcomas: A clinicopathologic study, 1965–1981Gynecologic Oncology, 1984
- Malignant mixed müllerian tumors of the uterusCancer, 1984
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983
- Treatment of advanced uterine sarcoma with adriamycinGynecologic Oncology, 1983
- Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tractGynecologic Oncology, 1982
- Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcomaCancer, 1982
- E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcomaEuropean Journal of Cancer (1965), 1979
- CIS-DICHLORODIAMMINEPLATINUM(II) IN ADVANCED SOFT-TISSUE AND BONY SARCOMAS - SOUTHWEST ONCOLOGY GROUP-STUDY1979